Bloomberg

Novartis achieves strong third quarter financial performance and pipeline progress
ITNews
Three new approvals and a positive CHMP recommendation in Europe In the third quarter, everolimus received two important approvals in the EU. First, everolimus was approved as Afinitor for the treatment of patients with advanced pancreatic ...
Novartis achieves strong third quarter financial performance and pipeline progressMarketWatch (press release)

all 32 news articles »